Abstract
Keeping in view the fact that genes coding microRNAs (miRNAs) have been found to be localized in chromosomal regions susceptible to genetic translocations, this study was addressed to identify and characterize the miRNAs that are present near/within the regions involved in genetic translocations characteristic of B-cell acute lymphoblastic leukemia (B-cell ALL). Out of six such identified miRNAs miR-196b was not only found to be significantly down-regulated in both EB-3 cell line as well as B-cell ALL patients as compared to that found in the corresponding controls, but also had the inherent capacity to down-regulate the highly expressed c-myc gene, a consequence of genetic translocation characteristic of EB-3 cells at both transcriptional and translational level. This phenomenon was in conformity with the observed reciprocal relationship between the expressed genes coding for miR-196b and c-myc in B-cells derived from ALL patients as well as c-myc gene was found to be a putative target of miR-196b as predicted by bioinformatic algorithms. Also down-regulation of c-myc gene was accompanied by decreased expressions of c-myc effector genes coding for hTERT, Bcl-2, and AATF. Based upon these results, we propose for the first time that miR-196b has the inherent capacity to down-regulate the overamplified c-myc gene recognized as a common pathognomonic feature leading to cancer in general and B-cell ALL in particular. Hence miR-196b can be assigned with the tumor suppressor function and can be of therapeutic importance in paving the way toward the treatment of B-cell ALL.
Similar content being viewed by others
References
Kent OA, Mendell JT (2006) A small piece in cancer puzzle: microRNAs as tumor suppressors and oncogenes. Oncogene 25:6188–6196
Lee RC, Feinbaum RL, Ambros V (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75:843–854
Wightman B, Ha I, Ruvkun G (2004) Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediator temporal pattern formation in C. elegans. Cell 75:855–862
Ambros V (2004) The functions of animal microRNAs. Nature 431:350–355
Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281–297
Carleton M, Cleary MA, Linsley PS (2007) MicroRNAs and cell cycle regulation. Cell Cycle 6:2127–2132
Calin GA, Dumitru CD, Shimizu M, Bichi R, Zuop S, Noch E, Aldler H, Rattan S, Keating M, Rai K et al (2002) Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 99:15524–15529
Metzler M, Wilda M, Busch K, Viehmann S, Borkhardt A (2004) High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma. Genes Chromosomes Cancer 39:167–169
Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M, Croce CM (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 101:2999–3004
Calin GA, Croce CM (2006) MicroRNAs and chromosomal abnormalities in cancer cells. Oncogene 25:6202–6210
McManus MT (2003) MicroRNAs and cancer. Semin Cancer Biol 13:253–258
Wijhoven BPL, Michael MZ, Watson DI (2007) MicroRNAs and cancer. Br J Sur 94:23–30
Gartel AL, Kandel EU (2008) miRNAs: little known mediators of oncogenesis. Semin Cancer Biol 18:103–110
Kaul D (1998) Receptor-CK and leukemogenesis. Leuk Res 22:562–564
Fabbri M, Garzon R, Andreeff M, Kantarjian HM, Garcia-Manero G, Calin GA (2008) MicroRNAs and noncoding RNAs in hematological malignancies:molecular, clinical and therapeutic implications. Leukemia 22:1095–1105
Schickel R, Boyerinas B, Park SM, Peter ME (2008) MicroRNAs: key players in immune system, differentiation, tumorigenesis and cell death. Oncogene 27:5959–5974
Pui CH, Evans WE (1998) Acute lymphoblastic leukemia. N Engl J Med 339:605–615
Pui CH, Relling MV, Downing JR (2004) Acute lymphoblastic leukemia. N Engl J Med 350:1535–1548
Hecht JL, Aster JC (2000) Molecular biology of Burkitt’s lymphoma. J Clin Oncol 18:3707–3721
Kaul D, Khanna A, Suman (2006) Evidence and nature of a novel miRNA encoded by HIV-1. Proc Indian Natl Sci Acad 72:91–95
Chomczynski P, Sacchi N (1987) Single step method of RNA isolation by acid guanidium thiocynate phenol chloroform extraction. Anal Biochem 162:156–159
John B, Enright AJ, Aravin A, Tuschl T, Sander C, Marks DS (2004) Human MicroRNA targets. PLoS Biol 2:e363
Sampson VB, Rong NH, Han J, Yang Q, Aris V, Soteropoulos P, Petrelli NJ, Dunn SP, Krueger LJ (2007) MicroRNA Let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. Cancer Res 67:9762–9770
Cimmino A, Calin GA, Fabbri M, Iorio M, Ferracin M, Shimizu M, Wojcik SE, Aqeilan RI, Zupo S, Dono M (2005) miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 102:13944–13949
Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A, Labourier E, Reinert KL, Brown D, Slack FJ (2005) RAS is regulated by the let-7 microRNA family. Cell 120:635–647
O’Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT (2005) c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435:839–843
Wiemer EAC (2007) The role of microRNAs in cancer: no small matter. Eur J Cancer 43:1529–1544
Cong YS, Wright WE, Shay JW (2002) Human telomerase and its regulation. Microbiol Mol Biol Rev 66:407–425
Hu BT, Insel RA (1999) Up-regulation of telomerase in human B lymphocytes occurs independently of cellular proliferation and with expression of the telomerase catalytic subunit. Eur J Immunol 29:3745–3753
Horikawa I, Cable PL, Afshari C et al (1999) Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene. Cancer Res 59:826–830
Wang J, Liu X, Jiang W et al (2000) Telomerase activity and expression of the telomerase catalytic subunit gene in non-small cell lung cancer: correlation with decreased apoptosis and clinical prognosis. Chin Med J 113:985–990
Fernandez PC, Frank SR, Wang L, Schroeder M, Liu S, Greene J, Cocito A, Amati B (2003) Genomic targets of the human c-Myc protein. Genes Dev 17:1115–1129
Kaul D, Mehrotra A (2007) Functional characterization of AATF transcriptome in human leukemic cells. Mol Cell Biochem 297:215–220
Kaul D, Ahlawat A, Gupta SD (2009) HIV-1 genome-encoded hiv1-mir-H1 impairs cellular responses to infection. Mol Cell Biochem 323:143–148
Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H, Harano T, Yatabe Y, Nagino M, Nimura Y, Mitsudomi T, Takahashi T (2004) Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 64:3753–3756
Chang C, Yu D, Lee YS, Wentzel EA, Arking DE, West KM, Dang CV, Thomas Tikhonenko A, Mendell JT (2008) Widespread microRNAs repression by Myc contributes to tumorigenesis. Nat Genet 40:43–50
Schotte D, Chau JCK, Sylvester G, Liu G, Chen C, van der Velden VHJ, Broekhuis MJC, Peters TCJM, Pieters R, den Boer ML (2009) Identification of new microRNA genes and aberrant microRNA profiles in childhood acute lymphoblastic leukemia. Leukemia 23:313–322
Popovic R, Riesbeck LE, Velu CS, Chaubey A, Zhang J, Achille NJ, Erfurth FE, Eaton K, Lu J, Grimes HL, Chen J, Rowley JD, Zeleznik-Le NJ (2009) Regulation of mir-196b by MLL and its overexpression by MLL fusions contributes to immortalization. Blood 113:3314–3322
Acknowledgement
The study is funded by Department of Biotechnology, Govt. of India, New Delhi.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bhatia, S., Kaul, D. & Varma, N. Potential tumor suppressive function of miR-196b in B-cell lineage acute lymphoblastic leukemia. Mol Cell Biochem 340, 97–106 (2010). https://doi.org/10.1007/s11010-010-0406-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-010-0406-9